会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明公开
    • 일본 뇌염 바이러스 유전자 피알엠이을 발현하는 돼지 아데노바이러스 3형
    • 重组蛋氨酸腺病毒3型表达日本ENCEPHALITIS病毒基因疫苗及其用途
    • KR1020040047485A
    • 2004-06-05
    • KR1020020075722
    • 2002-11-30
    • 대한민국(농림축산식품부 농림축산검역본부장)
    • 차상호박종현송재영안동준최은진김종염권준헌
    • C12N15/861
    • C12N15/861C07K14/005C12N2770/24034
    • PURPOSE: Recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME and use thereof are provided, thereby inducing immunity to Japanese encephalitis virus in human, and improving stability of the vaccine by using adenovirus. CONSTITUTION: A recombinant vector of porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME, pPAV3E3-prME(KCTC 10376BP), is prepared by removing E3 gene of porcine adenovirus type 3, and inserting the Japanese encephalitis virus gene prME under the control of E3 promoter, wherein the Japanese encephalitis virus gene prME has the nucleotide sequence set forth in SEQ ID NO: 1. A host cell transformed with the recombinant vector pPAV3E3-prME(KCTC 10376BP) is provided. The recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME(PAV3E3-prME) is obtained by culturing the transformed host cell. A vaccine for Japanese encephalitis virus comprises the recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene prME.
    • 目的:提供3型表达日本脑炎病毒基因prME的重组猪腺病毒及其用途,从而诱导人体对日本脑炎病毒的免疫,并通过使用腺病毒提高疫苗的稳定性。 构成:通过除去3型猪腺病毒的E3基因,并将日本脑炎病毒基因prME置于E3的控制下,制备3型表达日本脑炎病毒基因prME,pPAV3E3-prME(KCTC 10376BP)的猪腺病毒重组载体 启动子,其中日本脑炎病毒基因prME具有SEQ ID NO:1所示的核苷酸序列。提供用重组载体pPAV3E3-prME(KCTC 10376BP)转化的宿主细胞。 通过培养转化的宿主细胞获得表达日本脑炎病毒基因prME(PAV3E3-prME)的重组猪腺病毒3型。 日本脑炎病毒疫苗包含3型表达日本脑炎病毒基因prME的重组猪腺病毒。
    • 6. 发明公开
    • 일본 뇌염 바이러스 및 돼지 면역조절 유전자를 이용한 디엔에이 백신 및 그의 사용방법
    • 使用日本ENCEPHALITIS病毒和PORCINE免疫原性基因的DNA疫苗及其使用方法
    • KR1020040047483A
    • 2004-06-05
    • KR1020020075720
    • 2002-11-30
    • 대한민국(농림축산식품부 농림축산검역본부장)
    • 박종현차상호송재영안동준최은진김종염권준헌
    • C12N15/86
    • A61K39/12A61K39/0005A61K2039/53A61K2039/552
    • PURPOSE: A DNA vaccine using Japanese encephalitis virus and porcine immunoregulatory genes, and a method for using the same are provided, which DNA vaccine selectively uses strong cellular immunity and humoral immunity by change of genetic manipulation or administration pathway, minimizes side-effects by diluents in the administration area, inhibits pathogenicity recovering shown in live vaccine, and minimizes lowering of immunity when it is used with other disease vaccines. CONSTITUTION: The DNA vaccine using Japanese encephalitis virus and porcine immunoregulatory genes comprises a recombinant plasmid pSLIA-prME(KCTC 10378BP) containing Japanese encephalitis virus gene prME and a recombinant plasmid pSLIA-NS1(KCTC 10379BP) containing porcine immunoregulatory gene NS1, and further comprises a recombinant plasmid pSLIA-PIL-2(KCTC 10380) containing porcine interleukin-2 gene PIL-2, wherein the DNA vaccine is subcutaneously administered to pigs through the pig's tail. The method for preventing the infection of Japanese encephalitis virus comprises administering the recombinant plasmids pSLIIA-prME and pSLIA-NS1 into pigs, wherein the recombinant plasmid pSLIA-PIL-2 may be further administered into pigs.
    • 目的:提供使用日本脑炎病毒和猪免疫调节基因的DNA疫苗及其使用方法,该DNA疫苗通过改变遗传操作或给药途径选择性地使用强的细胞免疫和体液免疫,从而最小化稀释剂的副作用 在管理区域,抑制活疫苗中显示的致病性恢复,并且当与其他疾病疫苗一起使用时,可以最大限度地降低免疫力。 构成:使用日本脑炎病毒和猪免疫调节基因的DNA疫苗包含含有日本脑炎病毒基因prME的重组质粒pSLIA-prME(KCTC 10378BP)和含有猪免疫调节基因NS1的重组质粒pSLIA-NS1(KCTC 10379BP),并且还包含 包含猪白细胞介素-2基因PIL-2的重组质粒pSLIA-PIL-2(KCTC10380),其中将DNA疫苗通过猪尾皮皮下施用于猪。 防止日本脑炎病毒感染的方法包括将重组质粒pSLIIA-prME和pSLIA-NS1投入猪,其中可以将重组质粒pSLIA-PIL-2进一步施用于猪。
    • 10. 发明公开
    • 일본 뇌염 바이러스 유전자 엔에스1을 발현하는 돼지 아데노바이러스 3형
    • 重组蛋氨酸腺病毒3型表达日本ENCEPHALITIS病毒基因NS1及其用途
    • KR1020040047484A
    • 2004-06-05
    • KR1020020075721
    • 2002-11-30
    • 대한민국(농림축산식품부 농림축산검역본부장)
    • 차상호박종현송재영안동준최은진김종염권준헌
    • C12N15/861
    • C12N15/861C07K14/005C12N2770/24034
    • PURPOSE: Recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene NS1 and use thereof are provided, thereby inducing immunity to Japanese encephalitis virus in human, and improving stability of the vaccine by using adenovirus. CONSTITUTION: A recombinant vector of porcine adenovirus type 3 expressing Japanese encephalitis virus gene NS1, pPAV3E3-NS1(KCTC 10377BP), is prepared by removing E3 gene of porcine adenovirus type 3, and inserting the Japanese encephalitis virus gene NS1 under the control of E3 promoter, wherein the Japanese encephalitis virus gene NS1 has the nucleotide sequence set forth in SEQ ID NO: 1. A host cell transformed with the recombinant vector pPAV3E3-NS1(KCTC 10377BP) is provided. The recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene NS1(PAV3E3-NS1) is obtained by culturing the transformed host cell. A vaccine for Japanese encephalitis virus comprises the recombinant porcine adenovirus type 3 expressing Japanese encephalitis virus gene NS1.
    • 目的:提供3型表达日本脑炎病毒基因NS1的重组猪腺病毒及其用途,从而诱导人体对日本脑炎病毒的免疫,并通过使用腺病毒提高疫苗的稳定性。 构成:通过除去3型猪腺病毒的E3基因,并将日本脑炎病毒基因NS1插入到E3的控制下,制备3型表达日本脑炎病毒基因NS1,pPAV3E3-NS1(KCTC 10377BP)的猪腺病毒重组载体 启动子,其中日本脑炎病毒基因NS1具有SEQ ID NO:1所示的核苷酸序列。提供用重组载体pPAV3E3-NS1(KCTC 10377BP)转化的宿主细胞。 通过培养转化的宿主细胞获得3型表达日本脑炎病毒基因NS1(PAV3E3-NS1)的猪腺病毒。 日本脑炎病毒疫苗包含3型表达日本脑炎病毒基因NS1的重组猪腺病毒。